A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of DCC-2618 In Patients with Advanced c-KIT/PDGFRA Gastrointestinal Stromal TUmorS who have Received Prior Treatment with Imatinib, Sunitinib, and/or Rego
|Effective start/end date||11/1/17 → 5/31/21|
- DECIPHERA PHARMACEUTICALS, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.